Table 1.
Clinical characterization of the studied group.
| Characteristics | Survivors (n = 11) | Nonsurvivors (n = 16) | p |
|---|---|---|---|
| Age | 66 (41–75) | 55 (52–83) | 0.7586 |
| Female (n) | 5 | 10 | 0.3811 |
| SOFA | 5 (4–10) | 12 (8–12) | 0.0022 |
| Source of infection (n) | |||
| Peritonitis | 7 | 9 | |
| Pneumonia | 2 | 7 | |
| Other | 2 | 0 | |
| Mini-BAL samples (n) | 9 | 11 | |
| PB CD64 GMF | 1 208 (864–1 743) | 3 428 (1 772–4 369) | 0.0313 |
| PB HLA-DR GMF | 347 (251–473) | 342 (243–692) | 1.0000 |
Results are presented as median and P25–P74 percentiles.